Home > Delphinus Medical Technologies Salary

Delphinus Medical Technologies Salary

  • 19
  • 87
  • 48
Delphinus Medical Technologies average salary is $163,797, median salary is $163,797 with a salary range from $160,585 to $167,008.
Delphinus Medical Technologies salaries are collected from government agencies and companies. Each salary is associated with a real job position. Delphinus Medical Technologies salary statistics is not exclusive and is for reference only. They are presented "as is" and updated regularly.
Total 2 Delphinus Medical Technologies Salaries. Sorted by Date, page 1
Ranked By:
Job Title Salaries City Year More info
Financial Manager 167,008-167,008 New York, NY, 10001 2014 Delphinus Medical Technologies Financial Manager Salaries (2)
Delphinus Medical Technologies New York, NY Salaries
Financial Manager 160,585-160,585 New York, NY, 10001 2013 Delphinus Medical Technologies Financial Manager Salaries (2)
Delphinus Medical Technologies New York, NY Salaries
Calculate how much you could earn

It's FREE. Based on your input and our analysis.     How we do it?

All fields are required for calculation accuracy.

  • We will send you an email to access your personalized report.
  • We won’t share your email address

Delphinus Medical Technologies salary is full-time annual starting salary. Intern, contractor and hourly pay scale vary from regular exempt employee. Compensation depends on work experience, job location, bonus, benefits and other factors.

Real Jobs Salary - Salary List
Calculate Your Salary Ranking
Delphinus Medical Technolog... Jobs
See more Delphinus Medical Technologies Jobs»
Search All Jobs

JobCompare – Find open jobs faster
Delphinus Medical Tech... Information
  • Delphinus Medical Technologies Inc
  • Industry: Medical Equipment
  • City: Plymouth, MI
  • Delphinus Medical Technologies, LLC., is a Michigan company and a spin-off of the Barbara Ann Karmanos Cancer Institute (KCI). Delphinus has succeeded in building a three-dimensional full-breast ultrasound imaging device that effectively differentiates benign from malignant masses in breast cancer cases using a safe (non-ionizing), comfortable (non-compressing), and reliable (operator independent) patented technology. Utilizing multi-parametric ultrasound and sophisticated computer algorithms, rather than X-rays, SoftVue safely and comfortably screens women for breast cancer, assesses breast cancer risk, diagnoses breast diseases and monitors therapy.